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Hemoglobin changes during pregnancy and growth disturbances in the neonate G. Mau (Department of General Pediatrics, University of Kiel; Head: Professor Dr. H.-R. Wiedemann)
The extent to which anemias of pregnancy affect \ length of gestation and fetal growth varies among the many reports [l, 2, 6, 11, 12, 18, 22] . Because the hemoglobin (Hb) normally decreases during pregnancy, results obtained at varying times during pregnancy (e.g. during the first or the third trimester) are not comparable. Investigations about the role of the relative changes of hemoglobin during pregnancy have not been done. This study pursues that question from the data of the prospective Study on Pregnancy and Child Development of the Germany Research Council (Deutsche Forschungsgemeinschaft).
Material and Methods
Study patients entered the study during the first trimester and were examined throughout the pregnancy at four week intervals. Details of birth and infant outcome were accurately documented. All data were centrally collected and evaluated. Details of this study have been described by KOLLER [10] . Hemoglobin values of 4690 women were determined in the .first trimester upon admission to the study and agein in the third trimester (especially at the middle of the third trimester). Thus, individual changes could be assessed. Multiple births were excluded from the analysis. The method of hemoglobin determination varied among the 18 collaborating obstetric departments; thus, standardization and determination of the in whom the physiological hemodilution of the pregnancy had not occurred. (Tab. IV). These results were independent of parity, age, weight and socio-economic Status of the patient. A correlation of the findings with toxemia was attempted and patients were classified äs hypotensive, normotensive and hypertensive. The above described correlation was found in the hypertensive and normotensive patients, while patients with Wood pressures above 150 mm Hg had a notably increased incidence of both prematures and dysmatures with low hemoglobin values in the third trimester.
Curriculum vitae
Tab. IV. Incidence of hypotrophic newborns (weight < 10 th percentile) correlated with hemogiobin value in the first trimester (< 11.2 and > 12.9 g%) and hemogiobin changes to the third trimester. The described correlation between first trimester anemia and the occurence of dysmaturity must take into consideration these findings. Table 4 shows that women with a low first trimester hemogiobin and only a minimal increase have more frequently hypotrophic newborn infants with 12 % and 11.7 % respectively than those with higher initial values in whom the hemodilution of pregnancy has occurred (6.7 %). The poor outcome in women lacking the decrease in hemogiobin raises the mean for the group to that of the patients with a first trimester anemia.
Discussion
Even though these findings may appear slightly confusing the pathogenetic principle becomes recognizable if some already known facts are taken into consideration. It is known that the plasma volume increases by about 15 % more than the total amountof hemogiobin. This difference results in a hemodilution with a relative decrease in hemogiobin as.expressed in Hb g%. This decrease occurs generally between the 25 th and 36th gestational week and a prenatal hemogiobin of 12 g% is considered optimal. A failure of the hemogiobin to fall during pregnancy may thus indicate a relatively too low increase in plasma volume or a too large increase in hemogiobin. A high hemogiobin value leads necessarily to an increase in Wood viscosity. RÄIHÄ et al [14, 15, 16] , UNNERUS et al [3, 20] and BISHOP [5] have shown years ago th^ there is a correlation between the cardiac volume of the mother and the incidence of prematurity. These results have been criticized for methodical reasons because the values were not corrected for the maternal body size [2, 8, 17, 19] , however, body weight and size of the mother are correlated with the birth weight of the child äs well äs with the maternal cardiac volume. HYTTEN and PAINTIN [9] showed that even if body size is taken into consideration, the incidence of low birth weight infants increases with low plasma volume. In these studies a low cardiac volume was interpreted primarily äs an indication of decreased physical capacity. As a consequence in Helsinki the so-called cardiac volume program was initiated where women with low cardiac volumes were asked to avoid physical stress. This study meanwhile comprises 50,000 cases [21] and shows that primarily those women are at risk who do not show an increase of the cardiac volume during pregnancy, i.e. a lack or insufficient increase in plasma volume. It is possible that our results of the two hemogiobin determination assess the same phenomenon. Therefore, it maybe hypothesized that a lack of hemodilution with high initial hemogiobin values leads to fetal risk.
This risk is seen especially in the increase of hypotrophic newborns. The multivariant änalysis of the other indicators of maturity shows in addition that fatty tissue is reduced and that the infants have a relatively large head circumference in comparison to weight and length and thus resemble a genuine intrauterine growth retardation. The placentas are in part small but mature according to the criteria of BECKER [4] . It is difficult to assess the effect on the length of gestation because an increased duration of pregnancy leads normally to a decrease of hemogiobin and thus a premature delivery encounters higher hemogiobin values. Even though this influence and the variable examined cannot easily be separated, the results point towards an increased incidence of premature infants in women with lack of hemogiobin decrease. Our investigations leave unclarified which subordinate factor is the cause, e.g. whether it is a relative high viscosity of the blood or whether other factors such äs disturbances in blood distribution and placental perfusion play a role or whether there are compensatory processes with a relatively tpo large increase of the total hemoglobin. In summary, two risk groups can be identified:
1. women with initially low hemoglobin values and a failure to increase them. 2. women with higher initial values and a lack of decrease.
If our results should prove to be reproducible with adequate controls the easily followed variable hemoglobin should allow the proper identification of these women at risk. 
